GliTTher

GliTTHer is developing a precision medicine therapy for glioblastoma, the most aggressive form of brain tumor. The focus is on so-called glioma-initiating cells, which are responsible for tumor growth and usually survive conventional treatments. GliTTHer's technology aims to specifically target the particular metabolic weaknesses of these cells, while largely sparing healthy tissue. Combined with a companion diagnostic to identify suitable patients, this should enable individualized and effective treatment that prevents relapses and significantly improves survival and quality of life.